Skip to main content Accessibility help
×
Home
  • Print publication year: 2014
  • Online publication date: October 2014

Section 1 - Introduction to genetic mouse models of neurobehavioral disorders

References

Bevilacqua, L., Doly, S., Kaprio, J., et al. (2010) A populationspecific HTR2B stop codon predisposes to severe impulsivity. Nature 468: 1061–1066.
Crabbe, J.C., Wahlsten, D., and Dudek, B.C. (1999) Genetics of mouse behavior: interactions with laboratory environment. Science 284: 1670–1672.
DSM-5 (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edn (DSM-5). Washington, DC:American Psychiatric Association.
Insel, T.R. (2007) From animal models to model animals. Biol Psychiatry 62: 1337–1339.
Krishnan, V. and Nestler, E.J. (2008) The molecular neurobiology of depression. Nature 455: 894–902.
Mineur, Y.S., Belzung, C., and Crusio, W.E. (2006) Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice. Behav Brain Res 175: 43–50.
Mitchell, K.J., Huang, Z.J., Moghaddam, B., and Sawa, A. (2011) Following the genes: a framework for animal modeling of psychiatric disorders. BMC Biology 9: 76.
Nestler, E.J. and Hyman, S.E. (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13: 1161–1169.
Sakoda, L.C., Jorgenson, E., and Witte, J.S. (2013) Turning of COGS moves forward findings for hormonally mediated cancers. Nat Genet 45: 345–348.
Wahlsten, D., Bachmanov, A., Finn, D.A., and Crabbe, J.C. (2006). Stability of inbred mouse strain differences in behavior and brain size between laboratories and across decades. Proc Natl Acad Sci 103: 16364–16369.

References

Abernethy, A.P. and Wheeler, J.L. (2011) True translational research: bridging the three phases of translation through data and behavior. Transl Behav Med 1: 26–30.
Agid, Y., Buzsáki, G., Diamonds, D.M., et al. (2007) How can drug discovery for psychiatric disorders be improved? Nat Rev Drug Discov 6: 189–201.
Allain, H., Bentué-Ferrer, D., Zekri, O., et al. (1998) Experimental and clinical methods in the development of anti-Alzheimer drugs. Fund Clin Pharmacol 12: 13–29.
Anisman, H. and Matheson, K. (2005) Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev 29: 525–546.
Antony, P.M.A., Diederich, N.J., and Balling, R. (2011) Parkinson’s disease mouse models in translational research. Mamm Genome 22: 401–419.
Bailey, K.R., Rustay, N.R., and Crawley, J.N. (2006) Behavioral phenotyping of transgenic and knockout mice: practical concerns and potential pitfalls. ILAR J 47: 124–131.
Baker, E.J., Galloway, L., Jackson, B., Schmoyer, D., and Snoddy, J. (2004) MuTrack: a genome analysis of large-scale mutagenesis in the mouse. BMC Bioinformatics 5: 11.
Belzung, C. and Griebel, G. (2001) Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 125: 141–149.
Belzung, C. and Lemoine, M. (2011) Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. Biol Mood Anxiety Disord 1: 9.
Benatar, M. (2007) Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis 26: 1–13.
Bezard, E. (2006) A call for clinically driven experimental design in assessing neuroprotection in experimental Parkinsonism. Behav Pharmacol 17: 379–382.
Bird, S.J. and Brown Parlee, M. (2000) Of mice and men (and women and children): scientific and ethical implications of animal models. Prog Neuropsychopharmacol Biol Psychiatry 24: 1219–1227.
Bolon, B. (2004) Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research. Basic Clin Pharmacol Toxicol 95: 154–161.
Bolon, B. and Galbreath, E. (2002) Use of genetically engineered mice in drug discovery and development: wielding Occam’s razor to prune the product portfolio. Int J Toxicol 21: 55–64.
Bourin, M., Fiocco, A.J., and Clenet, F. (2001) How valuable are animal models in defining antidepressant activity? Human Psychopharmacol 16: 9–21.
Britt, D.W. (1997) A Conceptual Introduction to Modeling: Qualitative and Quantitative Perspectives. Mahwah, NJ: Lawrence Erlbaum Associates.
Brown, M.J. and Murray, K.A. (2006) Phenotyping of genetically engineered mce: humane, ethical, environmental, and husbandry issues. ILAR J 47: 118–123.
Brown, R.E., Stanford, L., and Schellinck, H.M. (2000) Developing standardized behavioral tests for knockout and mutant mice. ILAR J 41: 163–174.
Buehr, M., Hjorth, J.P., Hansen, A.K., and Sandøe, P. (2003) Genetically modified laboratory animals – what welfare problems do they face? J Appl Anim Welf Sci 6: 319–338.
Burne, T., Scott, E., van Swinderen, B., et al. (2010) Big ideas for small brains: what can psychiatry learn from worms, flies, bees and fish? Mol Psychiatry 16: 7–16.
Burrows, E.L., McOmish, C.E., and Hannan, A.J. (2011) Gene–environment interactions and construct validity in preclinical models of psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 35: 1376–1382.
Cavero, I. (2010) Safety Pharmacology Society: 9th Annual Meeting. Expert Opin Drug Saf 9: 365–378.
Cernak, I. (2005) Animal models of head trauma. NeuroRx 2: 410–422.
Chen, G., Henter, I.D., and Manji, H.K. (2010) Translational research in bipolar disorder: emerging insights from genetically based models. Mol Psychiatry 15: 883–895.
Chesler, E.J., Wang, J., Lu, L., et al. (2003) Genetic correlates of gene expression in recombinant inbred strains: a relational model system to explore neurobehavioral phenotypes. Neuroinformatics 1: 343–357.
Chesselet, M.F. and Richter, F. (2011) Modelling of Parkinson’s disease in mice. Lancet Neurol 10: 1108–1118.
Crabbe, J.C. and Morris, R.G.M. (2004) Festina lente: late-night thoughts on high-throughput screening of mouse behavior. Nature Neurosci 7: 1175–1179.
Crawley, J.N. (1999) Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res Protocols 835: 18–26.
Crusio, W.E. (2001) Genetic dissection of mouse exploratory behaviour. Behav Brain Res 125: 127–132.
Cryan, J.F. and Slattery, D.A. (2007) Animal models of mood disorders: recent developments. Curr Opin Psychiatry 20: 1–7.
Cryan, J.F. and Sweeney, F.F. (2011) The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br J Pharmacol 164: 1129–1161.
Dennis, M.B. (2002) Welfare issues of genetically modified animals. ILAR J 43: 100–109.
Depue, R.A. and Morrone-Strupinsky, J.V. (2005) A neurobehavioral model of affiliative bonding: implications for conceptualizing a human trait of affiliation. Behav Brain Sci 28(3): 313–395.
D’Mello, G.D. and Steckler, T. (1996) Animal models in cognitive behavioural pharmacology: an overview. Brain Res Cogn Brain Res 3: 345–352.
Doyle, A., McGarry, M.P., Lee, N.A., and Lee, J.J. (2012) The construction of transgenic and gene knockout/knockin mouse models of human disease. Transgenic Res 21: 327–349.
Drolet, B.C. and Lorenzi, N.M. (2011) Translational research: understanding the continuum from bench to bedside. Transl Res 157: 1–5.
Eifert, G.H., Forsyth, J.P., Zvolensky, M.J., and Lejuez, C.W. (1999) Moving from the laboratory to the real world and back again: increasing the relevance of laboratory examinations of anxiety sensitivity. Behav Ther 30: 273–283.
Einat, H. (2011) Strategies for the development of animal models for bipolar disorder: new opportunities and new challenges. In H.K. Manji and C.A. Zarate (eds) Behavioral Neurobiology of Bipolar Disorder and its Treatment: Current Topics in Behavioral Neurosciences 5. Berlin; Heidelberg: Springer-Verlag, pp. 69–86.
Elsea, S.H. and Lucas, R.E. (2002) The mousetrap: what we can learn when the mouse model does not mimic the human disease. ILAR J 43: 66–79.
Fenwick, N., Griffin, G., and Gauthier, C. (2009) The welfare of animals used in science: how the “Three Rs” ethic guides improvements. Can Vet J 50: 523–530.
Festing, M.F.W. (2004) Is the use of animals in biomedical research still necessary in 2002? Unfortunately, “yes.”Alt Lab Anim 32: 733–739.
Fleming, S.M. and Chesselet, M.-F. (2006) Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism. Behav Pharmacol 17: 383–391.
Frazer, A. and Morilak, D.A. (2005) What should animal models of depression model? Neurosc Biobehav Rev 29: 515–523.
Gavériaux-Ruff, C. and Kieffer, B.L. (2007) Conditional gene targeting in the mouse nervous system: insight into brain function and diseases. Pharmacol Ther 113: 619–634.
Geerts, H. (2009) Of mice and men: bridging the translational disconnect in CNS drug discovery. CNS Drugs 23(11): 915–926.
Gerrits, H., van Ingen Schenau, D.S., Bakker, N.E.C., et al. (2008) Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice. Genesis 46: 235–245.
Gershenfeld, H.K. and Paul, S.M. (1998) Towards a genetics of anxious temperament: from mice to men. Acta Psychiatrica Scand Suppl 393: 56–65.
Geyer, M.A. and Markou, A. (1995) Animal models of psychiatric disorders. In F.E. Bloom and D.J. Kupfer (eds) Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp. 787–798.
Geyer, M.A. and Markou, A. (2002) The role of preclinical models in the development of psychotropic drugs. In K.L. Davis, D. Charney, J.T. Coyle, and C. Nemeroff (eds) Neuropsychopharmacology: The Fifth Generation of Progress. American College of Neuropsychopharmacology, pp. 445–455.
Gottesman, I.I. and Gould, T.D. (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636–645.
Green, A.R., Gabrielsson, J., and Fone, K.C.F. (2011) Translational neuropharmacology and the appropriate and effective use of animal models. Br J Pharmacol 164: 1041–1043.
Grupe, A., Germer, S., Usaka, J., et al. (2001) In silico mapping of complex disease-related traits in mice. Science 292: 1915–1918.
Guala, F. (2003) Experimental localism and external validity. Phil Sci 70: 1195–1205.
Hamza, T.H., Chen, H., Hill-Burns, E.M., et al. (2011) Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson’s disease modifier gene via interaction with coffee. PLoS Genet 7: e1002237.
Hitzemann, R. (2000) Animal models of psychiatric disorders and their relevance to alcoholism. Alcohol Res Health 24: 149–158.
Holmes, P.V. (2003) Rodent models of depression: reexamining validity without anthropomorphic interference. Crit Rev Neurobiol 15: 142–174.
Holschneider, D.P., Bradesi, S., and Mayer, E.A. (2011) The role of experimental models in developing new treatments for irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 5: 43–57.
Homberg, J.R. (2013) Measuring behaviour in rodents: towards translational neuropsychiatric research. Behav Brain Res 236: 295–306.
Jegstrup, I., Thon, R., Hansen, A.K., and Riskes Hoitinga, M. (2003) Characterization of transgenic mice: a comparison of protocols for welfare evaluation and phenotype characterization of mice with a suggestion on a future certificate of instruction. Lab Animals 37: 1–9.
Joober, R., Boksa, P., Benkelfat, C., and Rouleau, G. (2002) Genetics of schizophrenia: from animal models to clinical studies. J Psychiatry Neurosci 27: 336–347.
Joubert, P.-E., Werneke, S.W., de la Calle, C., et al. (2012) Chikungunya virus-induced autophagy delays caspase-dependent cell death. J Exp Med 209: 1029–1047.
Jucker, M. (2010) The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med 16: 1210–1214.
Kazdin, A.E. and Rogers, T. (1978) On paradigms and recycled ideologies: analogue research revisited. Cogn Ther Res 2: 105–117.
Kell, D.B. and Oliver, S.G. (2003) Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. BioEssays 26: 99–105.
Kelly, C.D. (2006) Replicating empirical research in behavioral ecology: how and why it should be done but rarely ever is. Q Rev Biol 81: 221–236.
Kilkenny, C., Parsons, N., Kadyszewski, E., et al. (2009) Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS One 4: e7824.
Kimmelman, J. and London, A.J. (2011) Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty. PloS Med 8: e1001010.
Lander, B. and Atkinson-Grosjean, J. (2011) Translational science and the hidden research system in universities and academic hospitals: a case study. Soc Sci Med 72: 537–544.
le Bars, D., Gozariu, M., and Cadden, S.W. (2001) Animal models of nociception. Pharmacol Rev 53: 597–652.
Levin, J.R. (1998) What if there were no more bickering about statistical significance tests? Research in the Schools 5: 43–53.
Lindsay, R.M. and Ehrenberg, A.S.C. (1993) The design of replicated studies. Am Statistician 47: 217–228.
Lubow, R.E. (2005) Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophr Bull 31: 139–153.
Ludolph, A., Bendotti, C., Blaugrund, E., et al. (2010) Guidelines for preclinical animal research in ALS/MND: a consensus meeting. Amyotroph Lateral Scler 11: 38–45.
Lustig, C., Kozak, R., Sarter, M., Young, J.W., and Robbins, T.W. (2013) CNTRICS final animal model task selection: control of attention. Neurosci Biobehav Rev 37: 2099–2110.
Mace, F.C. (1996) In pursuit of general behavioral relations. J Appl Behav Anal 29: 557–563.
Malkesman, O., Austin, D.R., Chen, G., and Manji, H.K. (2009) Reverse translational strategies for developing animal models of bipolar disorder. Dis Model Mech 2: 238–245.
Manciocco, A., Chiarotti, F., Vitale, A., et al. (2009) The application of Russell and Burch 3R principle in rodent models of neurodegenerative disease: the case of Parkinson’s disease. Neurosci Biobehav Rev 33: 18–32.
Marcotte, E.R., Pearson, D.M., and Srivastava, L.K. (2001) Animal models of schizophrenia: a critical review. J Psychiatry Neurosci 26: 395–410.
Markou, A., Chiamulera, C., Geyer, M.A., Tricklebank, M., and Steckler, T. (2009) Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacol Rev 34: 74–89.
Massoud, T.F., Hademenos, G.J., Young, W.L., et al. (1998) Principles and philosophy of modeling in biomedical research. FASEB J 12: 275–285.
Matthews, D.J. and Kopczynski, J. (2001) Using model system genetics for drug-based target discovery. Drug Discov Today 6: 141–149.
Matthews, K., Christmas, D., Swan, J., and Sorrell, E. (2005) Animal models of depression: navigating through the clinical fog. Neurosci Biobehav Rev 29: 503–513.
McMillen, B.A. (1997) Toward a definition of a valid model of alcoholism: multiple animal models for multiple diseases. Alcohol 14: 409–419.
Mellor, D.J. (2010) Galloping colts, fetal feelings, and reassuring regulations: putting animal-welfare science into practice. J Vet Med Educ 37: 94–100.
Mertens, C. and Rülicke, T. (2000) Phenotype characterization and welfare assessment of transgenic rodents (mice). J Appl Anim Welf Sci 3: 127–139.
Mertens, C. and Rülicke, T. (2007) Welfare assessment and phenotype characterisation of transgenic mice. Alt Animal Exp 24: 46–48.
Miczek, K.A. and de Wit, H. (2008) Challenges for translational psychopharmacology research – some basic principles. Psychopharmacol 199: 291–301.
Mineur, Y.S. and Crusio, W.E. (2009) Behavioral effects of ventilated micro-environment housing in three inbred mouse strains. Physiol Behav 97: 334–340.
Mitchell, A.C. and Mirnics, K. (2012) Gene expression profiling of the brain: pondering facts and fiction. Neurobiol Dis 45: 3–7.
Mook, D.G. (1989) The myth of external validity. In L.W. Poon, D.C. Rubin, and B.A. Wilson (eds) Everyday Cognition in Adulthood and Late Life. Cambridge University Press, pp. 25–43.
Muma, J.R. (1993) The need for replication. J Speech Hear Res 36: 927–930.
Nelson, R.J. (1997) The use of genetic “knockout” mice in behavioral endocrinology research. Horm Behav 31: 188–196.
Nestler, E.J. and Hyman, S.E. (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13: 1161–1169.
Ng, Y.-K. (1995) Towards welfare biology: evolutionary economics of animal consciousness and suffering. Biol Phil 10: 255–285.
Öbrink, K.J. and Rehbinder, C. (2000) Animal definition: a necessity for the validity of animal experiments? Lab Anim 34: 121–130.
Ohl, F. and van der Staay, F.J. (2012) Animal welfare: at the interface between science and society. Vet J 192: 13–19.
Oliva, A.M., Salcedo, E., Hellier, J.L., et al. (2010) Toward a mouse neuroethology in the laboratory environment. PloS One 5: e11359.
Oliver, P.L. and Davies, K.E. (2012) New insights into behaviour using mouse ENU mutagenesis. Hum Mol Genet 21: R72–R81.
Ormandy, E.H., Dale, J., and Griffin, G. (2011) Genetic engineering of animals: ethical issues, including welfare concerns. Can Vet J 52: 544–550.
Palmer, A.R. (2000) Quasireplications and the contract of error: lessons from sex ratios, heritabilities and fluctuating asymmetry. Ann Rev Ecol System 31: 441–480.
Park, C.L. (2004) What is the value of replicating other studies? Res Eval 13: 189–195.
Plath, N., Lerdrup, L., Hjørringgaard Larsen, P., and Redrobe, J.P. (2011) Can small molecules provide truly effective enhancement of cognition? Current achievements and future directions. Expert Opin Investig Drugs 20: 795–811.
Porges, S.W. (2006) Asserting the role of biobehavioral sciences in translational research: the behavioral neurobiology revolution. Dev Psychopathol 18: 923–933.
Pratt, J., Winchester, C., Dawson, N., and Morris, B. (2012) Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. Nat Rev Drug Discov 11: 560–579.
Rand, M.S. (2008) Selection of biomedical animal models. In P.M. Conn (ed.) Sourcebook of Models for Biomedical Research. Totowa, NJ: Humana Press.
Rosenfield, P.L. (1992) The potential of transdisciplinary research for sustaining and extending linkages between health and social sciences. Soc Sci Med 35: 1343–l357.
Rosenthal, R. (1991) Replication in behavioral research. In J.W. Neuliep (ed.) Replication Research in the Social Sciences. Newbury Park, CA: Sage Publications, pp. 1–30.
Sabbagh, J.S., Kinney, J.W., and Cummings, J.L. (2012) Animal systems in the development of treatments for Alzheimer’s disease: challenges, methods, and implications. Neurobiol Aging 45: 3–7.
Sabrøe, I., Dockrell, D.H., Vogel, S.N., et al. (2007) Identifying and hurdling obstacles to translational research. Nat Rev Immunol 7: 77–82.
Salomé, N., Viltart, O., Darnaudéry, M., et al. (2002) Reliability of high and low anxiety-related behaviour: influence of laboratory environment and multifactorial analysis. Behav Brain Res 136: 227–237.
Sarter, M. and Bruno, J.P. (2002) Animal models in biological psychiatry. In H. D’Haenen, J.A. den Boer, and P. Willner (eds) Biological Psychiatry. John Wiley & Sons, pp. 37–44.
Sarter, M., Hagan, J., and Dudchenko, P. (1992) Behavioral screening for cognition enhancers: from indiscriminate to valid testing: part I. Psychopharmacologia 107: 144–159.
Schellinck, H.M., Cyr, D.P., and Brown, R.E. (2010) How many ways can mouse behavioral experiments go wrong? Confounding variables in mouse models of neurodegenerative diseases and how to control them. Adv Study Behav 41: 255–366.
Schuppli, C.A., Fraser, D., and McDonald, M. (2004) Expanding the three Rs to meet new challenges in humane animal experimentation. Alt Lab Anim 32: 525–532.
Scotti, M.A.L., Lee, G., Stevenson, S.A., et al. (2011) Behavioral and pharmacological assessment of a potential new mouse model for mania. Physiol Behav 103: 376–383.
Shadish, W.R. (1995) The logic of generalization: five principles common to experiments and ethnographies. Am J Comm Psychology 23: 419–428.
Silva, F. (1993) Psychometric Foundations and Behavioral Assessment. Newbury Park, CA: Sage Publications.
Sinha, R., Shaham, Y., and Heilig, M. (2011) Translational and reverse translational research on the role of stress in drug craving and relapse. Psychopharmacology 218: 69–82.
Smoller, J.W. and Tsuang, M.T. (1998) Panic and phobic anxiety: defining phenotypes for genetic studies. Am J Psychiatry 155: 1152–1162.
Snaith, M.R. and Törnell, J. (2002) The use of transgenic systems in pharmaceutical research. Brief Funct Genomic Proteomic 1: 119–130.
Stokols, D., Hall, K.L., Taylor, B.K., and Moser, R.P. (2008) The science of team science. Overview of the field and introduction to the supplement. Am J Prev Med 35: S77–S89.
Sufka, K.J., Feltenstein, M.W., Warnick, J.E., et al. (2006) Modeling the anxiety-depression continuum hypothesis in domestic fowl chicks. Behav Pharmacol 17: 681–689.
Swerdlow, N.R., Braff, D.L., and Geyer, M.A. (1999) Cross-species studies of sensorimotor gating of the startle reflex. Ann NY Acad Sci 877: 202–216.
Tecott, L.H. (2003) The genes and brains of mice and men. Am J Psychiatry 160: 646–656.
Tordjman, S., Drapier, D., Bonnot, O., et al. (2007) Animal models relevant to schizophrenia and autism: validity and limitations. Behav Genet 37: 61–78.
Townsley, M. and Johnson, S. (2008) The need for systematic replication and tests of validity in simulation. In L. Liu and J. Eck (eds) Artificial Crime Analysis Systems. Hershey, PA: Information Science Reference, pp. 1–18.
Trochim, W., Kane, C., Graham, M.J., and Pincus, H.A. (2011) Evaluating translational research: a process marker model. Clin Transl Sci 4: 153–162.
van Abeelen, J.H.F. (1966) Behavioural profiles of neurological mutant mice. Genetica 37: 149–158.
van den Buuse, M., Garner, B., Gogos, A., and Kusljic, S. (2005) Importance of animal models in schizophrenia research. Aust NZ J Psychiatry 39: 550–557.
van der Kooij, M.A. and Glennon, J.C. (2007) Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neurosci Biobehav Rev 31: 597–618.
van der Staay, F.J. (2006) Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy. Brain Res Rev 52: 131–159.
van der Staay, F.J., Arndt, S.S., and Nordquist, R.E. (2009) Evaluation of animal models of neurobehavioral disorders. Behav Brain Funct 5: 11.
van der Staay, F.J., Arndt, S.S., and Nordquist, R.E. (2010) The standardization–generalization dilemma: a way out. Genes Brain Behav 9: 849–855.
van der Worp, H.B., Howells, D.W., Sena, E.S., et al. (2010) Can animal models of disease reliably inform human studies? PLoS Med 7: e1000245.
van Meer, P. and Raber, J. (2005) Mouse behavioural analysis in systems biology. Biochem J 389: 593–610.
van Zutphen, L.F.M., Baumans, V., and Ohl, F. (eds) (2009) Handboek proefdierkunde. Proefidieren, dierproven, alternatieven en ethiek. Maarssen: Elsevier Gezondheidszorg.
van Zutphen, L.F.M. and De Deyn, P.P. (2000) Animal use in experimental neuropathology: provisions for animal welfare and ethics. Neurosci Res Comm 26: 149–160.
Viding, E. and Blakemore, S.-J. (2007) Endophenotype approach to developmental psychopathology: implications for autism research. Behav Genet 37: 51–60.
Wahlsten, D. (2011) Mouse Behavioral Testing: How to Use Mice in Behavioral Neuroscience. Amsterdam: Elsevier; Academic Press.
Wahlsten, D., Metten, P., Phillips, T.J., et al. (2003a) Different data from different labs: lessons from studies of gene–environment interaction. J Neurobiol 54: 283–311.
Wahlsten, D., Rustay, N.R., Metten, P., and Crabbe, J.C. (2003b) In search of a better mouse test. Trends Neurosci 26: 132–136.
Waldman, S.A. and Terzic, A. (2010) Clinical and translational science: from bench-bedside to global village. Clin Transl Sci 3: 254–257.
Wang, L., Simpson, H.B., and Dulawa, S.C. (2009) Assessing the validity of current mouse genetic models of obsessive–compulsive disorder. Behav Pharmacol 20: 119–133.
Wansleeben, C., van Gurp, L., Feitsma, H., et al. (2011) An ENU-mutagenesis screen in the mouse: identification of novel developmental gene functions. PLoS One 6: e19357.
Weerd, J.L. and Raber, J.M. (2005) Balancing animal research with animal well-being: establishment of goals and harmonization of approaches. ILAR 46: 118–128.
West, D.B., Iakougova, O., Olsson, C., et al. (2000) Mouse genetics/genomics: an effective approach for drug target discovery and validation. Med Res Rev 20: 216–230.
Weston, C.M., Bass, E.B., Ford, D.E., and Segal, J.B. (2010) Faculty involvement in translational research and interdisciplinary collaboration at a US academic medical center. J Invest Med 58: 770–776.
Whiteside, G.T., Adedoyin, A., and Leventhal, L. (2008) Predictive validity of animal pain models? A comparison of the pharmacokinetic–pharnacodynamic relationship for pain drugs in rats and humans. Neuropharmacology 54: 767–775.
Wickens, J.R., Hyland, B.I., and Tripp, G. (2011) Animal models to guide clinical drug development in ADHD: lost in translation? Br J Pharmacol 164: 1107–1128.
Willner, P. (1986) Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Prog Neuropsychopharmacolog Biol Psychiatry 10: 677–690.
Willner, P. (1998) Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134: 319–329.
Wong, P.C., Cai, H., Borchelt, D.R., and Price, D.L. (2002) Genetically engineered mouse models of neurodegenerative diseases. Nat Neurosci 5: 633–639.
Woolf, S.H. (2007) The meaning of translational research and why it matters. JAMA 299: 211–213.
Wright, C.D. (2002) Animal models of depression in neuropsychopharmacology qua Feyerabend philosophy of science. In S.P. Shodov (ed.) Advances in Philosophy Research. New York: NovaScience Publishers, pp. 129–148.
Würbel, H. (2000) Behaviour and the standardization fallacy. Nat Genet 26: 263.
Würbel, H. (2002) Behavioral phenotyping enhanced: beyond (environmental) standardization. Genes Brain Behav 1: 3–8.
Young, J.W., Zhou, X., and Geyer, M.A. (2010) Animal models of schizophrenia. In N.R. Swerdlow (ed.) Behavioral Neurobiology of Schizophrenia and its Treatment. Current Topics in Behavioral Neurosciences 4, pp. 391–433.
Zuckerman, M. (2005) It’s a long way up from comparative studies of animals to personality traits in humans. Behav Brain Sci 28: 370–371.